Literature DB >> 28408644

Human-derived gut microbiota modulates colonic secretion in mice by regulating 5-HT3 receptor expression via acetate production.

Yogesh Bhattarai1, Bradley A Schmidt2, David R Linden2, Eric D Larson3, Madhusudan Grover1, Arthur Beyder1, Gianrico Farrugia1, Purna C Kashyap4.   

Abstract

Serotonin [5-hydroxytryptamine (5-HT)], an important neurotransmitter and a paracrine messenger in the gastrointestinal tract, regulates intestinal secretion by its action primarily on 5-HT3 and 5-HT4 receptors. Recent studies highlight the role of gut microbiota in 5-HT biosynthesis. In this study, we determine whether human-derived gut microbiota affects host secretory response to 5-HT and 5-HT receptor expression. We used proximal colonic mucosa-submucosa preparation from age-matched Swiss Webster germ-free (GF) and humanized (HM; ex-GF colonized with human gut microbiota) mice. 5-HT evoked a significantly greater increase in short-circuit current (ΔIsc) in GF compared with HM mice. Additionally, 5-HT3 receptor mRNA and protein expression was significantly higher in GF compared with HM mice. Ondansetron, a 5-HT3 receptor antagonist, inhibited 5-HT-evoked ΔIsc in GF mice but not in HM mice. Furthermore, a 5-HT3 receptor-selective agonist, 2-methyl-5-hydroxytryptamine hydrochloride, evoked a significantly higher ΔIsc in GF compared with HM mice. Immunohistochemistry in 5-HT3A-green fluorescent protein mice localized 5-HT3 receptor expression to enterochromaffin cells in addition to nerve fibers. The significant difference in 5-HT-evoked ΔIsc between GF and HM mice persisted in the presence of tetrodotoxin (TTX) but was lost after ondansetron application in the presence of TTX. Application of acetate (10 mM) significantly lowered 5-HT3 receptor mRNA in GF mouse colonoids. We conclude that host secretory response to 5-HT may be modulated by gut microbiota regulation of 5-HT3 receptor expression via acetate production. Epithelial 5-HT3 receptor may function as a mediator of gut microbiota-driven change in intestinal secretion.NEW & NOTEWORTHY We found that gut microbiota alters serotonin (5-HT)-evoked intestinal secretion in a 5-HT3 receptor-dependent mechanism and gut microbiota metabolite acetate alters 5-HT3 receptor expression in colonoids.View this article's corresponding video summary at https://www.youtube.com/watch?v=aOMYJMuLTcw&feature=youtu.be.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  5-hydroxytryptamine type 3; irritable bowel syndrome; microbiome; motility; physiology; secretion

Mesh:

Substances:

Year:  2017        PMID: 28408644      PMCID: PMC5538830          DOI: 10.1152/ajpgi.00448.2016

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  39 in total

1.  Serotonin receptors for chloride secretion in hen colon.

Authors:  M B Hansen; N Bindslev
Journal:  Comp Biochem Physiol C       Date:  1989

2.  Distinct 5-HT receptors mediate the peristaltic reflex induced by mucosal stimuli in human and guinea pig intestine.

Authors:  A E Foxx-Orenstein; J F Kuemmerle; J R Grider
Journal:  Gastroenterology       Date:  1996-11       Impact factor: 22.682

3.  Expression and function of 5-HT3 receptors in the enteric neurons of mice lacking the serotonin transporter.

Authors:  Min-Tsai Liu; Stephen Rayport; Yan Jiang; Dennis L Murphy; Michael D Gershon
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-09-04       Impact factor: 4.052

4.  Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells.

Authors:  Christopher S Reigstad; Charles E Salmonson; John F Rainey; Joseph H Szurszewski; David R Linden; Justin L Sonnenburg; Gianrico Farrugia; Purna C Kashyap
Journal:  FASEB J       Date:  2014-12-30       Impact factor: 5.191

5.  Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity.

Authors:  Jill M Hoffman; Karl Tyler; Sarah J MacEachern; Onesmo B Balemba; Anthony C Johnson; Elice M Brooks; Hong Zhao; Greg M Swain; Peter L Moses; James J Galligan; Keith A Sharkey; Beverley Greenwood-Van Meerveld; Gary M Mawe
Journal:  Gastroenterology       Date:  2012-01-04       Impact factor: 22.682

6.  The role of the 5-HT4 receptor in Cl- secretion in human jejunal mucosa.

Authors:  M R Budhoo; R P Harris; J M Kellum
Journal:  Eur J Pharmacol       Date:  1996-10-24       Impact factor: 4.432

7.  Serotonin-induced alteration of colonic electrolyte transport in the rat.

Authors:  T W Zimmerman; H J Binder
Journal:  Gastroenterology       Date:  1984-02       Impact factor: 22.682

8.  The 5-HT3B subunit is a major determinant of serotonin-receptor function.

Authors:  P A Davies; M Pistis; M C Hanna; J A Peters; J J Lambert; T G Hales; E F Kirkness
Journal:  Nature       Date:  1999-01-28       Impact factor: 49.962

Review 9.  The Cys-loop superfamily of ligand-gated ion channels: the impact of receptor structure on function.

Authors:  C N Connolly; K A Wafford
Journal:  Biochem Soc Trans       Date:  2004-06       Impact factor: 5.407

10.  Structure, function and diversity of the healthy human microbiome.

Authors: 
Journal:  Nature       Date:  2012-06-13       Impact factor: 49.962

View more
  25 in total

1.  Branched Short-Chain Fatty Acid Isovaleric Acid Causes Colonic Smooth Muscle Relaxation via cAMP/PKA Pathway.

Authors:  Bryan A Blakeney; Molly S Crowe; Sunila Mahavadi; Karnam S Murthy; John R Grider
Journal:  Dig Dis Sci       Date:  2018-12-17       Impact factor: 3.199

Review 2.  The Gut Microbiome in Adult and Pediatric Functional Gastrointestinal Disorders.

Authors:  Andrea Shin; Geoffrey A Preidis; Robert Shulman; Purna C Kashyap
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-25       Impact factor: 11.382

Review 3.  Autism Spectrum Disorder as a Brain-Gut-Microbiome Axis Disorder.

Authors:  Virginia Saurman; Kara G Margolis; Ruth Ann Luna
Journal:  Dig Dis Sci       Date:  2020-03       Impact factor: 3.199

Review 4.  Novel aspects of enteric serotonergic signaling in health and brain-gut disease.

Authors:  Andrew Del Colle; Narek Israelyan; Kara Gross Margolis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-11-04       Impact factor: 4.052

Review 5.  Intestinal secretory mechanisms and diarrhea.

Authors:  Stephen J Keely; Kim E Barrett
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-02-16       Impact factor: 4.052

Review 6.  Enterochromaffin Cells-Gut Microbiota Crosstalk: Underpinning the Symptoms, Pathogenesis, and Pharmacotherapy in Disorders of Gut-Brain Interaction.

Authors:  Lai Wei; Rajan Singh; Uday C Ghoshal
Journal:  J Neurogastroenterol Motil       Date:  2022-06-20       Impact factor: 4.725

7.  Gut Microbiota-Produced Tryptamine Activates an Epithelial G-Protein-Coupled Receptor to Increase Colonic Secretion.

Authors:  Yogesh Bhattarai; Brianna B Williams; Eric J Battaglioli; Weston R Whitaker; Lisa Till; Madhusudan Grover; David R Linden; Yasutada Akiba; Karunya K Kandimalla; Nicholas C Zachos; Jonathan D Kaunitz; Justin L Sonnenburg; Michael A Fischbach; Gianrico Farrugia; Purna C Kashyap
Journal:  Cell Host Microbe       Date:  2018-06-13       Impact factor: 21.023

8.  Effect of Akkermansia muciniphila, Faecalibacterium prausnitzii, and Their Extracellular Vesicles on the Serotonin System in Intestinal Epithelial Cells.

Authors:  Rezvan Yaghoubfar; Ava Behrouzi; Ehsan Zare Banadkoki; Fatemeh Ashrafian; Arezou Lari; Farzam Vaziri; Seyed Ali Nojoumi; Abolfazl Fateh; Shohreh Khatami; Seyed Davar Siadat
Journal:  Probiotics Antimicrob Proteins       Date:  2021-04-14       Impact factor: 4.609

9.  Functional Gastrointestinal Disorders and the Microbiome-What Is the Best Strategy for Moving Microbiome-based Therapies for Functional Gastrointestinal Disorders into the Clinic?

Authors:  Ruben A T Mars; Mary Frith; Purna C Kashyap
Journal:  Gastroenterology       Date:  2020-11-28       Impact factor: 22.682

10.  Association of 5-Hydroxytryptamine 3 Receptor Antagonists With the Prognosis of Liver Failure.

Authors:  Yuting Chen; Jingkang Sun; Xiude Fan; Xiaoyun Wang; Lu Zeng; Xiaoge Zhang; Kun Zhang; Na Li; Qunying Han; Zhengwen Liu
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.